96 related articles for article (PubMed ID: 9470845)
21. An intronic deletion in TP53 gene causes exon 6 skipping in breast cancer.
Voglino G; Castello S; Silengo L; Stefanuto G; Friard O; Ferrara G; Fessia L
Eur J Cancer; 1997 Aug; 33(9):1479-83. PubMed ID: 9337692
[TBL] [Abstract][Full Text] [Related]
22. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
23. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
[TBL] [Abstract][Full Text] [Related]
24. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.
Pang S; Taneja S; Dardashti K; Cohan P; Kaboo R; Sokoloff M; Tso CL; Dekernion JB; Belldegrun AS
Hum Gene Ther; 1995 Nov; 6(11):1417-26. PubMed ID: 8573614
[TBL] [Abstract][Full Text] [Related]
25. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
26. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
[TBL] [Abstract][Full Text] [Related]
27. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen in serum of women with breast cancer.
Giai M; Yu H; Roagna R; Ponzone R; Katsaros D; Levesque MA; Diamandis EP
Br J Cancer; 1995 Sep; 72(3):728-31. PubMed ID: 7545417
[TBL] [Abstract][Full Text] [Related]
29. Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.
Fadlon EJ; Rees RC; McIntyre C; Sharrard RM; Lawry J; Hamdy FC
Br J Cancer; 1996 Aug; 74(3):400-5. PubMed ID: 8695355
[TBL] [Abstract][Full Text] [Related]
30. Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: comparison with the results of immunohistochemistry.
Schneider J; Rubio MP; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
Eur J Cancer; 1994; 30A(4):504-8. PubMed ID: 8018409
[TBL] [Abstract][Full Text] [Related]
31. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
32. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets.
Ward BD; Hendrickson BC; Judkins T; Deffenbaugh AM; Leclair B; Ward BE; Scholl T
J Mol Diagn; 2005 Feb; 7(1):139-42. PubMed ID: 15681486
[TBL] [Abstract][Full Text] [Related]
33. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
[TBL] [Abstract][Full Text] [Related]
34. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
Varley JM; Brammar WJ; Lane DP; Swallow JE; Dolan C; Walker RA
Oncogene; 1991 Mar; 6(3):413-21. PubMed ID: 2011397
[TBL] [Abstract][Full Text] [Related]
35. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
36. Frequency of expression of prostate-specific antigen mRNA in lung tumors.
Zarghami N; Levesque M; D'Costa M; Angelopoulou K; Diamandis EP
Am J Clin Pathol; 1997 Aug; 108(2):184-90. PubMed ID: 9260759
[TBL] [Abstract][Full Text] [Related]
37. The role of p53 mutations in bilateral breast carcinoma.
Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ
Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
39. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
Nylander K; Nilsson P; Mehle C; Roos G
Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
[TBL] [Abstract][Full Text] [Related]
40. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
